论文部分内容阅读
目的:研究治疗过敏性紫癜患儿采取孟鲁司特钠的临床效果。方法:选择我院2015年4月-2016年10月纳入的64例过敏性紫癜患儿,按照入院顺序分为两组,其中32例患儿采取常规治疗方式作为对照组,另32例患儿在对照组基础上采取孟鲁司特钠作为研究组,比较两组患儿的临床效果。结果:经过观察两组患儿的临床效果看出,研究组患儿各项症状体征消失时间均比对照组时间少;且总有效率93.75%比对照组总有效率81.25%高,差别均具有统计学意义(P<0.05)。结论:治疗过敏性紫癜患儿采取孟鲁司特钠效果显著,快速缓解临床症状,缩短病情恢复时间,有效提高患儿生存质量。
Objective: To study the clinical effect of taking montelukast sodium in children with Henoch-Schonlein purpura. Methods: A total of 64 children with Henoch-Schonlein purpura who were enrolled in our hospital from April 2015 to October 2016 were divided into two groups according to admission sequence. Among them, 32 children were treated by conventional therapy as control group and 32 children On the basis of the control group, montelukast sodium was taken as the research group to compare the clinical effects of the two groups of children. Results: After observing the clinical effects of the two groups of children, all the symptoms and signs of the study group disappeared less than the control group; and the total effective rate was 93.75% higher than the control group, the total effective rate was 81.25% Statistical significance (P <0.05). Conclusion: The treatment of patients with Henoch-Schonlein purpura with montelukast sodium has a significant effect, which can quickly relieve clinical symptoms, shorten the recovery time and effectively improve the quality of life of children.